» Articles » PMID: 38261070

Timing of Prognostic Discussions in People with Advanced Cancer: a Systematic Review

Overview
Specialties Critical Care
Oncology
Date 2024 Jan 23
PMID 38261070
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Many people with cancer (patients) want to know their prognosis (a quantitative estimate of their life expectancy) but this is often not discussed or poorly communicated. The optimal timing of prognostic discussions with people with advanced cancer is highly personalised and complex. We aimed to find, organise, and summarise research regarding the timing of discussions of prognosis with people with advanced cancer.

Methods: We conducted a systematic review of publications from databases, clinical practice guidelines, and grey literature from inception to 2023. We also searched the reference lists of systematic reviews, editorials, and clinical trial registries. Eligibility criteria included publications regarding adults with advanced cancer that reported a timepoint when a discussion of prognosis occurred or should occur.

Results: We included 63 of 798 identified references; most of which were cross-sectional cohort studies with a range of 4-9105 participants. Doctors and patients agreed on several timepoints including at diagnosis of advanced cancer, when the patient asked, upon disease progression, when there were no further anti-cancer treatments, and when recommending palliative care. Most of these timepoints aligned with published guidelines and expert recommendations. Other recommended timepoints depended on the doctor's clinical judgement, such as when the patient 'needed to know' or when the patient 'seemed ready'.

Conclusions: Prognostic discussions with people with advanced cancer need to be individualised, and there are several key timepoints when doctors should attempt to initiate these conversations. These recommended timepoints can inform clinical trial design and communication training for doctors to help improve prognostic understanding.

References
1.
Russell B, Ward A . Deciding what information is necessary: do patients with advanced cancer want to know all the details?. Cancer Manag Res. 2011; 3:191-9. PMC: 3139480. DOI: 10.2147/CMR.S12998. View

2.
Horlait M, Chambaere K, Pardon K, Deliens L, Van Belle S . What are the barriers faced by medical oncologists in initiating discussion of palliative care? A qualitative study in Flanders, Belgium. Support Care Cancer. 2016; 24(9):3873-81. DOI: 10.1007/s00520-016-3211-5. View

3.
Hui D, Paiva C, Del Fabbro E, Steer C, Naberhuis J, van de Wetering M . Prognostication in advanced cancer: update and directions for future research. Support Care Cancer. 2019; 27(6):1973-1984. PMC: 6500464. DOI: 10.1007/s00520-019-04727-y. View

4.
Gordon E, Daugherty C . 'Hitting you over the head': oncologists' disclosure of prognosis to advanced cancer patients. Bioethics. 2003; 17(2):142-68. DOI: 10.1111/1467-8519.00330. View

5.
Mori M, Shimizu C, Ogawa A, Okusaka T, Yoshida S, Morita T . A National Survey to Systematically Identify Factors Associated With Oncologists' Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions?. Oncologist. 2015; 20(11):1304-11. PMC: 4718424. DOI: 10.1634/theoncologist.2015-0147. View